Advances in Cancer Immunotherapy™ - Online Modules

Overview

As a component of our regional, live programs held in 2016, SITC is pleased to offer free online introductory, CME-/CE-certified programs. These programs provide an overview of basic immunology principles and the mechanisms and clinical applications of immunotherapy for melanoma, lung cancer and genitourinary cancers.

With the opportunity to complete any number of the six available modules at your convenience, you don’t want to miss out on this opportunity! Access the modules here.

aci17-Online-clr.png

Access the Modules

CMEuniversity.pngThe modules, hosted by CME University, are available free of charge. Access each module by clicking the corresponding links below.

Login credentials are required to access the modules. They can be obtained by registering for an account here.

Target Audience

These modules have been designed to meet the educational needs of physicians, pharmacists, registered nurses and other healthcare professionals involved in the care of patients with cancer.

Estimated Time to Complete All Modules: 3.75 hours

Module 1: Immunology and Immunotherapy 101 for the Non-Immunologist

This module will teach you to:

  • Describe the components of the immune system.
  • Differentiate between adaptive vs. innate immune systems.
  • Recognize the barriers to effective immunotherapy.

Available for credit until June 30, 2017.

  • Physicians – maximum of 0.75 AMA PRA Category 1 Credits™
  • Pharmacists – 0.75 contact hours (0.075 CEUs)
  • Nurses – 0.7 contact hours



Module 3: Immunotherapy for the Treatment of Genitourinary Cancers

This module will teach you to:

  • Determine clinical applications of immunotherapy treatments for genitourinary cancers through case study support.
  • Identify treatment management and adverse events through case study support.

Available for credit until September 30, 2017.

  • Physicians – maximum of 0.25 AMA PRA Category 1 Credits™
  • Pharmacists – 0.25 contact hours (0.025 CEUs)
  • Nurses – 0.2 contact hours

Module 5: Immunotherapy for the Treatment of Melanoma

This module will teach you to:

  • Determine clinical applications of immunotherapy treatments for melanoma through case study support.
  • Identify treatment management and adverse events through case study support.

Available for credit until November 30, 2017.

  • Physicians – maximum of 0.5 AMA PRA Category 1 Credits™
  • Pharmacists – 0.5 contact hours (0.025 CEUs)
  • Nurses – 0.5 contact hours

Module 2: Basic Principles of Tumor Immunotherapy

This module will teach you to:

  • Discuss the key mechanisms and terminology of tumor immunology and immunotherapy.
  • Describe the role of immunity in cancer and approaches to tumor immunotherapy.

Available for credit until September 30, 2017.

  • Physicians – maximum of 1.0 AMA PRA Category 1 Credits™
  • Pharmacists – 1.0 contact hours (0.10 CEUs)
  • Nurses – 0.8 contact hours
     Designated for 0.3 pharmacotherapy contact hours for Advance Practice Registered Nurses

Module 4: Immunotherapy for the Treatment of Lung Cancer

This module will teach you to:

  • Determine clinical applications of immunotherapy treatments for lung cancer through case study support.
  • Identify treatment management and adverse events through case study support.

Available for credit until October 31, 2017.

  • Physicians – maximum of 0.5 AMA PRA Category 1 Credits™
  • Pharmacists – 0.5 contact hours (0.025 CEUs)
  • Nurses – 0.5 contact hours

Module 6: Immunotherapy on the Horizon

This module will teach you to:

  • Discuss promising research on potential new therapies for different types of cancer.
  • Identify challenges in the advancement of immune-mediated therapies for cancer treatment.

Available for credit until December 31, 2017.

  • Physicians – maximum of 0.75 AMA PRA Category 1 Credits™
  • Pharmacists – 0.75 contact hours (0.05 CEUs)
  • Nurses – 0.7 contact hours

Advances in Cancer Immunotherapy™ – Faculty

Module 1

Christian Capitini, MD
University of Wisconsin

Module 2

Patrick Ott, MD, PhD
Dana-Farber Cancer Institute

Module 3

Susan F. Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center

Module 4

Deepa Rangachari, MD
Beth Israel Deaconess Medical Center

Module 5

Elizabeth Buchbinder, MD
Dana-Farber Cancer Institute

Module 6

Morganna Freeman, DO, FACP
The Angeles Clinic & Research Institute

Postgraduate Institute for MedicineSITC Logo  

Jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer 

The 2016 Advances in Cancer Immunotherapy™ series were supported in part by independent medical educational grants from
AstraZeneca, Bristol-Myers Squibb, Genentech, and Merck & Co., Inc.